title: Best medical intervention for arterial disease or wishful thinking.
authors.affiliation: Baker IDI Heart and Diabetes Institute and the National Research Institute, Melbourne, Victoria, Australia. a.abbott@nsri.org.au
authors.forename: A
authors.initials: A
authors.lastname: Abbott
mesh_terms: D000959:Antihypertensive Agents / Q000627:therapeutic use; D058070:Asymptomatic Diseases; D002317:Cardiovascular Agents / Q000627:therapeutic use*; D002340:Carotid Artery Diseases / Q000150:complications / Q000188:drug therapy*; D002561:Cerebrovascular Disorders / Q000209:etiology / Q000517:prevention & control*; D016894:Endarterectomy, Carotid; D019317:Evidence-Based Medicine; D005343:Fibrinolytic Agents / Q000627:therapeutic use; D005858:Germany; D019983:Guideline Adherence; D006801:Humans; D007004:Hypoglycemic Agents / Q000627:therapeutic use; D000960:Hypolipidemic Agents / Q000627:therapeutic use; D009313:National Health Programs; D010043:Outcome and Process Assessment, Health Care / Q000706:statistics & numerical data; D017410:Practice Guidelines as Topic; D010818:Practice Patterns, Physicians' / Q000706:statistics & numerical data; D018570:Risk Assessment; D012307:Risk Factors; D016896:Treatment Outcome
chemical_list: D000959:Antihypertensive Agents; D002317:Cardiovascular Agents; D005343:Fibrinolytic Agents; D007004:Hypoglycemic Agents; D000960:Hypolipidemic Agents